Study for people with Liver Cancer

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor University Health Network, Toronto
Registry number NCT07628751
Started 11 May 2026 Today 16 October 2026 Estimated completion 1 April 2032

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Trans Tasman Radiation Oncology Group Waratah Australia Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 218

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1\) Histological or radiological diagnosis of single, new HCC with largest diameter =8 cm (BCLC stage 0 or A).

* a) If prior history of HCC, the prior HCC must have been:

* Early stage, solitary HCC, =5 cm in size and,

* Have arisen within a different liver segment to the current HCC and,

* Treated with curative intent therapy \>2 years prior with no evidence of active disease at the site.

* 2\) As per local multidisciplinary HCC meeting consensus patient is suitable for percutaneous thermal ablation and/or transarterial therapies and not suitable for or declined liver resection and not planned for liver transplantation.

* 3\) Child-Pugh score =B7\* with no or diuretic-controlled ascites

* 4\) ECOG performance status =2

* 5\) Platelets =50x109/L, Haemoglobin =80 g/L, Neutrophils =1.0x109/L, INR \<1.8 (except if on therapeutic anticoagulation)

* 6\) 18 years of age or older and able to provide written consent

Exclusion Criteria:

* 1\) Presence of multifocal HCC, macrovascular invasion or extrahepatic disease

* 2\) Prior treatment for any HCC within last 2 years.

* 3\) Clinically evident ascites or hepatic encephalopathy

* 4\) Prior abdominal radiation therapy that would preclude the delivery of protocol defined SABR to the tumour.

* 5\) Untreated Hepatitis B or C

* 6\) Known additional invasive malignancy (excluding non-melanoma skin cancer) that is progressing or required treatment within the last 2 years.

* 7\) Pregnancy

Dates on the record

Started 11 May 2026
Estimated completion 1 April 2032
Registry last updated 5 June 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 5 June 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.